CHRS Coherus Oncology, Inc.
Nasdaq · SEC CIK 1512762 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 108 since 2021-07-08, latest 2026-06-09 21:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ryan Michael Lee | Dir | — | — |
| McMichael Bryan J | CFO | — | — |
| O'Donnell-Tormey Jill | Dir | — | — |
| Newton Charles W. | Dir | — | — |
| Newcomer Lee Nisley | Dir | — | — |
| Satvat Ali J. | Dir | — | — |
| Karachun Rita A | Dir | — | — |
| Wahlstrom Mats | Dir | — | — |
| Lanfear Dennis M | Pres, CEO, Dir | — | — |
Transactions 56
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 21:57 | 2026-06-05 | CHRS | Satvat Ali J. | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:43 | 2026-06-05 | CHRS | Karachun Rita A | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:42 | 2026-06-05 | CHRS | Newcomer Lee Nisley | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:41 | 2026-06-05 | CHRS | Ryan Michael Lee | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:41 | 2026-06-05 | CHRS | O'Donnell-Tormey Jill | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:40 | 2026-06-05 | CHRS | Wahlstrom Mats | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:39 | 2026-06-05 | CHRS | Newton Charles W. | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-01-26 | 2026-01-22 | CHRS | McMichael Bryan J | CFO | A - Grant | $0.00 | +112.5K | 133.7K | +530% | $0 |
| D | 2026-01-26 | 2026-01-23 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | A - Grant | $0.00 | +375.0K | 1.05M | +56% | $0 |
| 2026-01-22 | 2026-01-20 | CHRS | McMichael Bryan J | CFO | F - Tax | $1.55 | -1,715 | 21.2K | -7% | -$2,658 | |
| 2026-01-22 | 2026-01-20 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $1.55 | -11.8K | 673.2K | -2% | -$18.4K | |
| I | 2025-05-28 | 2025-05-23 | CHRS | Wahlstrom Mats | Dir | S - Sale | $0.74 | -100.0K | 0 | -100% | -$74.0K |
| 2025-01-22 | 2025-01-20 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $1.39 | -4,858 | 82.1K | -6% | -$6,753 | |
| 2025-01-22 | 2025-01-20 | CHRS | McMichael Bryan J | CFO | F - Tax | $1.39 | -1,711 | 23.0K | -7% | -$2,378 | |
| 2025-01-22 | 2025-01-20 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $1.39 | -11.8K | 685.1K | -2% | -$16.4K | |
| 2025-01-10 | 2025-01-07 | CHRS | McMichael Bryan J | CFO | F - Tax | $1.57 | -1,711 | 24.7K | -6% | -$2,686 | |
| D | 2025-01-07 | 2025-01-04 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $1.66 | -2,277 | 86.9K | -3% | -$3,780 |
| 2025-01-07 | 2025-01-04 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $1.66 | -11.8K | 696.9K | -2% | -$19.6K | |
| 2024-12-17 | 2024-12-13 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $1.61 | -2,073 | 89.2K | -2% | -$3,338 | |
| 2024-02-15 | 2024-02-09 | CHRS | Wahlstrom Mats | Dir | G - Gift | $0.00 | -100.0K | 0 | -100% | $0 | |
| I | 2024-02-15 | 2024-02-09 | CHRS | Wahlstrom Mats | Dir | G - Gift | $0.00 | +100.0K | 100.0K | New | $0 |
| DM | 2024-02-05 | 2024-02-01 | CHRS | Wahlstrom Mats | Dir | M - OptEx | $1.67 | +60.0K | 100.0K | +150% | +$100.2K |
| 2024-01-23 | 2024-01-20 | CHRS | McMichael Bryan J | See Remarks | F - Tax | $2.44 | -1,707 | 23.0K | -7% | -$4,165 | |
| 2024-01-23 | 2024-01-20 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $2.44 | -11.2K | 708.7K | -2% | -$27.4K | |
| 2024-01-23 | 2024-01-20 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $2.44 | -4,854 | 81.3K | -6% | -$11.8K | |
| 2024-01-09 | 2024-01-07 | CHRS | McMichael Bryan J | See Remarks | F - Tax | $2.87 | -1,707 | 24.7K | -6% | -$4,899 | |
| D | 2024-01-08 | 2024-01-04 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $2.92 | -11.8K | 719.9K | -2% | -$34.4K |
| 2024-01-08 | 2024-01-04 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $2.92 | -2,275 | 86.1K | -3% | -$6,643 | |
| 2024-01-03 | 2023-12-31 | CHRS | Stilwell McDavid | CFO | F - Tax | $3.33 | -18.4K | 75.3K | -20% | -$61.4K | |
| 2023-12-15 | 2023-12-13 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $2.37 | -2,049 | 88.4K | -2% | -$4,856 | |
| DM | 2023-11-24 | 2023-11-22 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | M - OptEx | $1.42 | +299.9K | 954.8K | +46% | +$425.9K |
| D | 2023-11-24 | 2023-11-22 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | S - Sale+OE | $2.02 | -223.1K | 731.7K | -23% | -$450.7K |
| 2023-04-04 | 2023-04-01 | CHRS | Reider Paul | Chief Commercial Off | F - Tax | $6.84 | -2,451 | 87.1K | -3% | -$16.8K | |
| 2023-04-04 | 2023-04-01 | CHRS | Stilwell McDavid | CFO | F - Tax | $6.84 | -3,457 | 102.3K | -3% | -$23.6K | |
| 2023-04-04 | 2023-03-31 | CHRS | Vexler Vladimir | CSO | F - Tax | $6.84 | -16.3K | 116.4K | -12% | -$111.3K | |
| 2023-01-24 | 2023-01-20 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | A - Grant | $0.00 | +86.2K | 654.9K | +15% | $0 | |
| 2023-01-24 | 2023-01-20 | CHRS | Vexler Vladimir | CSO | A - Grant | $0.00 | +40.0K | 131.3K | +44% | $0 | |
| 2023-01-24 | 2023-01-20 | CHRS | Stilwell McDavid | CFO | A - Grant | $0.00 | +40.0K | 104.2K | +62% | $0 | |
| 2023-01-24 | 2023-01-20 | CHRS | McMichael Bryan J | See Remarks | A - Grant | $0.00 | +12.5K | 26.4K | +90% | $0 | |
| M | 2023-01-12 | 2023-01-10+ | CHRS | Vexler Vladimir | CSO | F - Tax | $10.05 | -7,204 | 94.9K | -7% | -$72.4K |
| 2023-01-10 | 2023-01-07 | CHRS | McMichael Bryan J | See Remarks | F - Tax | $9.58 | -1,699 | 13.9K | -11% | -$16.3K | |
| D | 2023-01-06 | 2023-01-04 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $9.87 | -10.9K | 568.6K | -2% | -$107.6K |
| D | 2023-01-06 | 2023-01-04 | CHRS | Stilwell McDavid | CFO | F - Tax | $9.87 | -5,437 | 64.2K | -8% | -$53.7K |
| D | 2023-01-06 | 2023-01-04 | CHRS | Vexler Vladimir | CSO | F - Tax | $9.87 | -5,437 | 98.5K | -5% | -$53.7K |
| I | 2023-01-04 | 2022-12-30 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | G - Gift | $0.00 | -4,000 | 432.7K | -0.9% | $0 |
| 2022-04-05 | 2022-04-01 | CHRS | Vexler Vladimir | CSO | F - Tax | $12.85 | -3,458 | 104.0K | -3% | -$44.4K | |
| 2022-04-05 | 2022-04-01 | CHRS | Stilwell McDavid | CFO | F - Tax | $12.85 | -3,458 | 69.7K | -5% | -$44.4K | |
| DM | 2022-03-01 | 2022-02-25+ | CHRS | Wahlstrom Mats | Dir | A - Grant | $4.47 | +40.0K | 40.0K | New | +$178.9K |
| M | 2022-01-12 | 2022-01-10+ | CHRS | Vexler Vladimir | CSO | F - Tax | $14.33 | -7,733 | 111.0K | -7% | -$110.8K |
| D | 2022-01-06 | 2022-01-04 | CHRS | Stilwell McDavid | CFO | A - Grant | $0.00 | +40.0K | 73.1K | +121% | $0 |
| D | 2022-01-06 | 2022-01-04 | CHRS | Vexler Vladimir | CSO | A - Grant | $0.00 | +40.0K | 115.2K | +53% | $0 |
| D | 2022-01-06 | 2022-01-04 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | A - Grant | $0.00 | +86.2K | 579.5K | +17% | $0 |
| I | 2021-11-23 | 2021-11-17 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 436.7K | -2% | $0 |
| 2021-10-19 | 2021-10-15 | CHRS | Stilwell McDavid | CFO | S - Sale | $16.80 | -3,507 | 31.6K | -10% | -$58.9K | |
| MI | 2021-09-29 | 2021-09-27+ | CHRS | HEALY JAMES | Dir | S - Sale | $16.68 | -434.6K | 334.4K | -57% | -$7.25M |
| D | 2021-07-08 | 2021-07-06 | CHRS | Anicetti Vincent R | COO | A - Grant | $0.00 | +50.0K | 124.8K | +67% | $0 |
Purchase Sale Sale after option exercise All abbreviations